Cargando…
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
BACKGROUND: Previous research suggests the therapeutic cancer vaccine L-BLP25 potentially provides a survival benefit in patients with locally advanced unresectable stage III non-small cell lung carcinoma (NSCLC). These promising findings prompted the phase III study, INSPIRE, in patients of East-As...
Autores principales: | Wu, Yi-Long, Park, Keunchil, Soo, Ross A, Sun, Yan, Tyroller, Karin, Wages, David, Ely, Guy, Yang, James Chih-Hsin, Mok, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203100/ https://www.ncbi.nlm.nih.gov/pubmed/21982342 http://dx.doi.org/10.1186/1471-2407-11-430 |
Ejemplares similares
-
Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapy
por: Kao, Chiao-Jung, et al.
Publicado: (2013) -
L-BLP25 vaccine plus letrozole for breast cancer: Is translation possible?
por: DeGregorio, Michael, et al.
Publicado: (2012) -
iBLP: An XGBoost-Based Predictor for Identifying Bioluminescent Proteins
por: Zhang, Dan, et al.
Publicado: (2021) -
Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model
por: Wurz, Gregory T, et al.
Publicado: (2013) -
Escherichia coli Braun Lipoprotein (BLP) exhibits endotoxemia – like pathology in Swiss albino mice
por: Lakshmikanth, Chikkamenahalli Lakshminarayana, et al.
Publicado: (2016)